Juan Manuel Hernández Molina-rekin lankidetzan egindako argitalpenak (15)

2011

  1. Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method

    International Journal of Antimicrobial Agents

  2. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2315-2322

2010

  1. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 122-125

2008

  1. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative

    Journal of Chemotherapy

  2. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis

    International Journal of Antimicrobial Agents, Vol. 31, Núm. 6, pp. 540-543

2006

  1. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One™

    Mycoses, Vol. 49, Núm. 4, pp. 293-297

2005

  1. Amphotericin B colloidal dispersion. Survey of in vitro antifungal activity. Antifungal activity of Amphocil®, amphotericin B and fluconazole

    Mikologia Lekarska, Vol. 12, Núm. 1, pp. 5-10

  2. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 3, pp. 317-319

2004

  1. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: Comparison of the sensititre yeast one® and NCCLS M38-A reference methods

    Journal of Chemotherapy, Vol. 16, Núm. 5, pp. 468-473

2002

  1. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P

    Chemotherapy, Vol. 48, Núm. 4-5, pp. 224-231

2001

  1. Actividad del itraconazol frente a aislamientos clínicos de Aspergillus spp. y Fusarium spp. determinada por el método M38-P del NCCLS

    Revista Espanola de Quimioterapia, Vol. 14, Núm. 3, pp. 281-285

2000

  1. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

    Chemotherapy, Vol. 46, Núm. 4, pp. 235-244

1999

  1. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing

    Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96

  2. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients

    Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 97-100

1996

  1. Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad in vitro a los antifúngicos: Método de difusión en disco

    Revista Iberoamericana de Micologia, Vol. 13, Núm. SUPPL. 2